Printer Friendly

Browse Clinical trials topic

Research subtopic

Articles

1-300 out of 571 article(s) nextnext page
Title Author Type Date Words
AstraZeneca-jabbed up to 3 times more likely to get Covid than Pfizer, study claims; Scientists at Imperial College London have used estimates from clinical trial data, including Public Health England, to suggest the AstraZeneca jab preventing symptoms of Covid less than Pfizer. By, Ryan Merrifield Jul 16, 2021 591
Arrowhead Pharmaceuticals Initiates Phase 2b Study of Investigational ARO-ANG3 for Treatment of Mixed Dyslipidemia. Jun 30, 2021 365
Ampio Pharmaceuticals initiates patient randomization and dosing in AP-019 Phase II study of inhaled Ampion in COVID-19 respiratory distress. Jun 28, 2021 211
Ampio Pharmaceuticals initiates patient randomization and dosing in AP-019 Phase II study of inhaled Ampion in COVID-19 respiratory distress. Jun 28, 2021 212
Patient Randomization and Dosing Starts in Ampio Pharmaceuticals AP-019 Phase II Study of Inhaled Ampion in COVID-19 Respiratory Distress. Jun 28, 2021 285
Medicenna submits clinical trial application in Australia for study of MDNA11. Report Jun 23, 2021 317
Innovent Biologics meets overall survival primary endpoint in phase 3 ORIENT-15 study. Clinical report Jun 23, 2021 193
Innovent Biologics meets overall survival primary endpoint in phase 3 ORIENT-15 study. Clinical report Jun 23, 2021 192
Sorrento Therapeutics Phase 2 abivertinib studies have completed enrollment. Clinical report Jun 22, 2021 180
Cassava selects Premier Research for Phase 3 of Alzheimer's program. Jun 21, 2021 162
Biogen announces first patient dosed in phase 3 clinical study of TOPAZ-1. Clinical report Jun 17, 2021 262
Otonomy initiates expansion of Phase 1/2 clinical trial for OTO-413. Clinical report Jun 15, 2021 168
Terns Pharmaceuticals reports results from phase 2a LIFT study of TERN-101. Clinical report Jun 14, 2021 299
NPRA approves clinical study of another Covid-19 vaccine, says Dr Noor Hisham. Jun 5, 2021 186
Algernon Pharmaceuticals expands Ifenprodil research to pancreatic cancer in new clinical study. Clinical report Jun 4, 2021 372
Tonix Pharmaceuticals presents results from Phase 3 RELIEF study of TNX-102 SL. Clinical report Jun 3, 2021 254
Can-Fite BioPharma to initiate phase IIb NASH study on Namodenoson. Jun 2, 2021 212
Chinese inactivated vaccines effective against COVID-19 in phase-3 human trials, - study. May 31, 2021 284
Sanofi, GSK initiate Phase 3 clinical efficacy study of COVID vaccine candidate. Clinical report May 27, 2021 227
Volunteers needed for booster jabs clinical trial; MUST BE 18-65 AND HAD FIRST DOSE OF PFIZER COVID-19 JAB. May 14, 2021 451
Algernon Pharmaceuticals reports findings from Ifenprodil Phase 2b/3 coronavirus trial may be positive for idiopathic pulmonary fibrosis (IPF) study. Clinical report May 13, 2021 325
Sio Gene Therapies announces data from clinical trial studying AXO-AAV-GM1. Clinical report May 13, 2021 438
Vaxart: First subject enrolled in Phase 1b norovirus boosting regimen study. Report May 4, 2021 197
Rezolute announces study results from Phase 1a of RZ402. May 4, 2021 311
Guardion Health Sciences initiates placebo-controlled trial of GlaucoCetin. May 3, 2021 167
Why are emerging countries popular for clinical research? Struver, V.; Ibeneme, S.C. Report May 1, 2021 6502
Imugene has HER-Vaxx Phase 1B Data published in prestigious clinical cancer research journal. Apr 30, 2021 264
Imugene has HER-Vaxx Phase 1B Data published in prestigious clinical cancer research journal. Apr 30, 2021 264
Xencor Doses First Subject in Phase 1 Study of XmAb564, an Engineered IL-2 Cytokine in Development for Autoimmune Diseases. Apr 29, 2021 336
G1 Therapeutics announces initiation of Phase 3 study of COSELA. Clinical report Apr 28, 2021 321
AIM ImmunoTech completes dosing of Cohort 2 in Phase 1 study of Ampligen. Apr 27, 2021 206
Corbus Pharmaceuticals completes enrollment in Phase 2 study of Lenabasum. Clinical report Apr 20, 2021 175
Lyndra reports encouraging results from Phase 2 study of LYN-005 for weekly treatment of schizophrenia. Apr 19, 2021 231
Lyndra reports encouraging results from Phase 2 study of LYN-005 for weekly treatment of schizophrenia. Apr 19, 2021 232
Longeveron announces completion of Phase I/II study of lomecel-b infusion. Clinical report Apr 15, 2021 402
Mix and match vaccine trial to expand to include Moderna and Novavax trials; Researchers have been investigating alternating doses of the Oxford/Astrazeneca and Pfizer vaccines -the first two jabs to be rolled out in the UK -since February. By, Mikey Smith & Nina Massey Apr 14, 2021 798
Zacks Small-Cap Research initiates coverage on Tiziana Life Sciences, which it expects to advance foralumab into "multiple clinical trials" this year. Apr 13, 2021 400
Zacks Small-Cap Research initiates coverage on Tiziana Life Sciences, which it expects to advance foralumab into "multiple clinical trials" this year. Apr 13, 2021 400
Anavex says DSMB recommends continuation of Phase 2/3 trials of ANAVEX 2-73. Clinical report Apr 12, 2021 292
Kiniksa announces results for mavrilimumab phase 2 trial in COVID-19 patients. Clinical report Apr 12, 2021 503
AIM ImmunoTech reports no serious adverse events in dosing of Cohort 1 in Phase 1 study of Ampligen drug's safety as an intranasal therapy. Apr 8, 2021 404
Grifols Phase 3 study in hospitalized Covid patients did not meet endpoints. Apr 2, 2021 181
SpringsWorks Therapeutics doses first patient in Phase 1b nirogacestat study. Apr 1, 2021 207
Botanix Pharmaceuticals receives approval for BTX 1702 Rosacea clinical study. Mar 31, 2021 603
KM Biologics Releases Phase I Clinical Study Results of a Live Attenuated Tetravalent Dengue Vaccine. Report Mar 25, 2021 380
Frequency Therapeutics releases new data from two FX-322 clinical studies. Mar 23, 2021 582
Three new Covid symptoms to look for as medics demand 'urgent' new clinical study; Experts say there is now a desperate need for a "carefully conducted clinical and diagnostic study to understand the long-term effects" of the virus as it continues to mutate and spread. By, Neil Shaw & Sam Elliott Clinical report Mar 22, 2021 417
Effect of Melatonin on Delirium After on-Pump Coronary Artery Bypass Graft Surgery: A Randomized Clinical Trial. Zadeh, Fatemeh Javaherforoosh; Janatmakan, Farahzad; Shafaeebejestan, Emad; Jorairahmadi, Sara Clinical report Mar 1, 2021 4577
Comments on Effects of routine physiotherapy with and without neuromobilization in the management of internal shoulder impingement syndrome: A randomized controlled trial. Rooma Rouf Chughtai and Farooq Azam Rathore Feb 24, 2021 1107
Metagenomi Adds Immuno-oncology Clinical Research Experts to its Scientific Advisory Board. Feb 24, 2021 459
Why clinical trials are important in medical research. Feb 24, 2021 345
Local trial finds arthritis drug can combat C-19; DERRIFORD PLAYS ITS PART IN LIFE-SAVING CLINICAL STUDY. CLARE AINSWORTH clare.ainsworth@reachplc.com @clarejardine1 Clinical report Feb 12, 2021 410
Revelation Biosciences Approved to Initiate a Multiple Dose Cohort to Phase 1 Clinical Study of Experimental Treatment for Respiratory Viral Infection, Including COVID-19. Feb 3, 2021 670
Humanigen Completes Enrollment in Phase 3 Study of Lenzilumab in Hospitalized Patients with COVID-19. Jan 29, 2021 427
Denovo Biopharma doses first patient in biomarker guided Phase three clinical study of DB102 in combination with temozolomide and radiation. Clinical report Jan 11, 2021 258
Denovo Biopharma doses first patient in biomarker guided Phase three clinical study of DB102 in combination with temozolomide and radiation. Clinical report Jan 11, 2021 262
Muhyiddin: Third phase clinical research for Covid-19 vaccine to start on Jan 21, first country outside of China to conduct study. Jan 11, 2021 453
REMD Biotherapeutics Completes Enrollment, Posts Top-line Results of a Phase 2 Clinical Study of Volagidemab (REMD-477) in Patients with Type 1 Diabetes. Clinical report Jan 7, 2021 367
Arcturus Therapeutics Approved by Singapore Health Sciences Authority to Proceed with Phase 2 Study of ARCT-021 Vaccine Candidate and Provides New and Updated Clinical and Preclinical Data. Report Dec 29, 2020 316
Researches find China's CAS COVID-19 vaccine candidate induces immune response in mid-stage trials. Dec 23, 2020 349
Researches find China's CAS COVID-19 vaccine candidate induces immune response in mid-stage trials. Dec 23, 2020 345
Covid-19 vaccine trials in Pakistan shows encouraging results: Scientist claims. Dec 22, 2020 472
First Patient Randomized in Phase 2 Trial of FSD201 for the Treatment of Hospitalized Patients with COVID-19. Clinical report Dec 15, 2020 425
Continuation Of Phase 1/2 CYNKCOVID Study. Clinical report Dec 14, 2020 228
Birch bark derivative gel effective for EB in phase 3 study. Salamon, Maureen Dec 1, 2020 875
"Anti-lice Protector Shampoo": Clinical Study Shows Lack of Efficacy of Coconut Oil Derivatives in the Elimination of Head Louse Infestation/"Anti-lice Protector Shampoo": Klinik Calisma, Hindistan Cevizi Yagi icin Etkinligin Olmadigini Gosteriyor. Burgess, Ian Faisal; Burgess, Nazma Akhter Clinical report Dec 1, 2020 3116
Semaglutide shows promise in NASH phase 2 study. Johnson, Kate Dec 1, 2020 862
AstraZeneca COVID-19 vaccine shows encouraging phase II results in peer-reviewed study. Clinical report Nov 20, 2020 324
Volunteers urged to help vital Covid studies in final-stage vaccine trials. LISA O'BRIEN lisa.obrien@mnamedia.co.uk Nov 18, 2020 598
Volunteers urged to help vital Covid studies in final-stage vaccine trials. LISA O'BRIEN lisa.obrien@mnamedia.co.uk Nov 18, 2020 598
Kangpu Biopharmaceuticals starts Phase Ib/IIa clinical study of KPG-818 in Systemic Lupus Erythematosus patients. Nov 18, 2020 177
Kangpu Biopharmaceuticals starts Phase Ib/IIa clinical study of KPG-818 in Systemic Lupus Erythematosus patients. Nov 18, 2020 181
Humanigen doses first COVID-19 patient with Lenzilumab at MedStar Washington Hospital Centre in Phase 3 clinical study. Clinical report Nov 2, 2020 222
Humanigen doses first COVID-19 patient with Lenzilumab at MedStar Washington Hospital Centre in Phase 3 clinical study. Clinical report Nov 2, 2020 226
Covid-19 vaccine trial gets positive public response. Nov 1, 2020 989
Algernon wins Data and Safety Monitoring Board approval to continue its Phase 2b/3 human study of Ifenprodil to treat COVID-19. Oct 31, 2020 465
Clinical study of different doses of atorvastatin combined with febuxostat in patients with gout and carotid atherosclerosis. Zheng Zhang, Ming-hua Xu, Feng-ju Wei and Li-na Shang Clinical report Oct 31, 2020 3025
First Patient Dosed at MedStar Washington Hospital Center in Phase 3 Clinical Study of Lenzilumab in COVID-19. Clinical report Oct 30, 2020 382
Oncimmune says lung blood test part of a clinical study assessing the screening potential of the technology. Clinical report Oct 29, 2020 296
Scientists developing Covid-19 'one-minute' breath test Volunteers aged 18-84 now wanted to trial new vaccine. Oct 28, 2020 616
Early trial results of Oxford University and AstraZeneca's COVID-19 vaccine indicate it produces robust immune response in elderly. Oct 26, 2020 257
Early trial results of Oxford University and AstraZeneca's COVID-19 vaccine indicate it produces robust immune response in elderly. Oct 26, 2020 253
Britain to infect healthy volunteers with virus in vaccine challenge trials. William Booth and Carolyn Y. Johnson The Washington Post Oct 21, 2020 886
Gilead, Galapagos presents data from Phase 2b/3 trial of filgotinib. Oct 12, 2020 563
Kiniksa announces data from Phase 2 trial of mavrilimumab. Oct 6, 2020 540
First Patient Enrolled in Phase 2 Study for the Treatment of Dravet Syndrome With EPX-100. Oct 5, 2020 325
Study shows Guardant Health liquid biopsy accelerates clinical trial enrollment. Oct 5, 2020 214
Eisai starts lorcaserin phase three clinical study. Clinical report Oct 1, 2020 220
Eisai starts lorcaserin phase three clinical study. Clinical report Oct 1, 2020 216
Revelation Biosciences Cleared to Start a Phase 1 Clinical Study of REVTx-99 an Experimental Treatment for COVID-19. Oct 1, 2020 551
Anesthetic Efficacy of Lidocaine/Ketorolac in Inferior Alveolar Nerve Block in Patients with Irreversible Pulpitis: A Randomized Clinical Trial. Faghihian, Hessamoddin; Faghihian, Reyhaneh; Khademi, Abbasali; Aggarwal, Vivek Clinical report Oct 1, 2020 3776
Merck announces findings from Phase 3 EORTC1325/KEYNOTE-054 trial. Sep 20, 2020 164
Axsome Therapeutics presents new data from GEMINI Phase 3 trial. Clinical report Sep 14, 2020 566
Cassava Sciences announces results of Phase 2b study of sumifilam. Clinical report Sep 14, 2020 1202
Blade Therapeutics Reaches Enrollment Goal for Phase 2 Study of Lead Investigational Therapy BLD-2660 in Treating Patients With COVID-19 Pneumonia. Clinical report Sep 14, 2020 204
Anavex completes ANAVEX 2-73 U.S. Phase 2 Rett Syndrome trial. Clinical report Sep 10, 2020 256
Chi-Med initiates FRESCO-2 Phase III registration study of fruquintinib. Sep 4, 2020 190
Early Results Of Russian Vaccine Trials Suggest Candidates Are Safe. Sep 4, 2020 831
Dietary Supplement Clinical Research in the Age of COVID-19: Challenges & Opportunities: The fundamental importance of ensuring studies are well-designed has been magnified by challenges brought about by COVID-19. Ghassemi, Annahita; Huber, Luke Sep 1, 2020 1129
Novan initiates B-SIMPLE4 Phase 3 study of SB206 for molluscum. Clinical report Aug 31, 2020 285
Shenmayizhi Formula Combined with Ginkgo Extract Tablets for the Treatment of Vascular Dementia: A Randomized, Double-Blind, Controlled Trial. Zhang, Huiqin; Cao, Yu; Pei, Hui; Wang, Huichan; Ma, Lina; Wang, Zhiyong; Diao, Xuemei; Yang, Yang; Clinical report Aug 31, 2020 6826
TRITON Phase 3b study results presented at ESC 2020. Aug 30, 2020 316
MyoKardia presents results from Phase 2 EXPLORER-HCM trial of Mavacamten. Aug 30, 2020 517
OP-ED: Sinovac vaccine trial debate: A response to icddr,b. Aug 25, 2020 1852
ReiThera's GRAd-COV2 vaccine candidate in Phase 1 clinical study in Italy. Aug 24, 2020 296
ReiThera's GRAd-COV2 vaccine candidate in Phase 1 clinical study in Italy. Aug 24, 2020 300
I-Mab doses first patient with Plonmarlimab in phase 1b rheumatoid arthritis study. Aug 18, 2020 181
I-Mab doses first patient with Plonmarlimab in phase 1b rheumatoid arthritis study. Aug 18, 2020 177
I-MAB doses first patient in Phase 1b study of plonmarlimab in RA. Aug 17, 2020 160
Blade Therapeutics Updates Enrollment Progress for Phase 2 Study of Lead Investigational Therapy BLD-2660 in Treating Patients with COVID-19 Pneumonia. Clinical report Aug 12, 2020 398
Catalyst Clinical Research Combines with Ce3 to Deliver Oncology CRO Solution. Aug 10, 2020 220
RedHill Biopharma Phase 2/3 COVID-19 study approved in Mexico. Aug 6, 2020 220
MUST TO TAKE BREAKTHROUGH VACCINE TO HUMAN TRIALS SHORTLY. Aug 4, 2020 766
Durect started recruiting Phase 2 DUR-928 study in COVID patients. Clinical report Aug 3, 2020 185
Revive Therapeutics announces FDA approval of Phase 3 bucillamine trial. Jul 31, 2020 312
Effect of Single Administration of Mulberry Milk on the Cognitive Function of 6-12-Year-Old Children: Results from a Randomized, Placebo-Controlled, Crossover Study. Thukham-mee, Wipawee; Wattanathorn, Jintanporn; Kirisattayakul, Woranan; Wannanon, Panakaporn Clinical report Jul 31, 2020 8387
In Vitro and Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Efficacy and Safety of Nine Antiacne Medicinal Plants. Said, Omar; Khamaysi, Iyad; Kmail, Abdalsalam; Fulder, Stephen; AboFarekh, Basheer; Amin, Riyad; Dar Clinical report Jul 31, 2020 8255
Effects of Kamishoyosan, a Traditional Japanese Medicine, on Menopausal Symptoms: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial. Takamatsu, Kiyoshi; Ogawa, Mariko; Higuchi, Tsuyoshi; Takeda, Takashi; Hayashi, Kunihiko; Mizunuma, Jul 31, 2020 4976
Effect of Missing Data Imputation on Deep Learning Prediction Performance for Vesicoureteral Reflux and Recurrent Urinary Tract Infection Clinical Study. Kose, Timur; Ozgur, Su; Cosgun, Erdal; Keskinoglu, Ahmet; Keskinoglu, Pembe Report Jul 31, 2020 9645
RedHill Biopharma initiates global Phase 2/3 study for COVID-19. Jul 30, 2020 196
Lexaria Bioscience gets approval for CBD DehydraTECH hypertension study in Europe. Jul 29, 2020 376
Pfizer, BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Commence Pivotal Phase 2/3 Global Study. Clinical report Jul 28, 2020 890
RedHill Biopharma submits CTAs in Brazil, Mexico for Phase 2/3 COVID-19 program. Jul 22, 2020 344
A SHOT IN THE ARM; 6 Daily Record MORE AT DAILYRECORD.CO.UK Tuesday, July 21, 2020 DAILY RECORD Tuesday, July 21, 2020 MORE AT DAILYRECORD.CO.UK PAGE 7 HOPES OF RESEARCH BREAKTHROUGH >>>>Vaccine trial boost as body is trained to fight deadly disease >>>>Injection could be ready for use within 6 months, experts say. PIPPA CRERAR Jul 21, 2020 906
Oxford coronavirus vaccine safe and promising according to Phase 1 results published in the Lancet. Jul 21, 2020 1349
Thousands part of clinical trials; Praise for 65,000 participants who are helping research. RICHARD GUTTRIDGE richard.guttridge@mnamedia.co.uk Jul 20, 2020 311
Oxford University COVID-19 vaccine hopes rise with strong trial results. Jul 17, 2020 358
Algernon unveils first US clinical trial site in Florida for Phase 2b/3 human study of Ifenprodil as potential coronavirus treatment. Jul 17, 2020 523
RedHill Biopharma receives approval for Phase 2/3 COVID-19 study. Jul 16, 2020 350
'AWARE for All' event to focus on clinical trial disparities. Submitted by Center for Information and Study on Clinical Research Participation Jul 15, 2020 430
Enanta announces clinical trial progress for ED-514. Jul 9, 2020 213
CytoDyn says leronlimab prevents transmission of simian HIV in pre-clinical study on macaques. Clinical report Jul 9, 2020 441
MGC Pharmaceuticals expands ArtemiC Phase II clinical trial for COVID-19 to India; selected for WHO research task force. Jul 3, 2020 637
COVID-19 vaccine trial: They deliberately infected themselves. Jay Hilotin Jul 2, 2020 2619
ChromaDex announces results of new clinical studies of Niagen. Clinical report Jun 30, 2020 226
Biocurcumin as Radiosensitiser for Cervical Cancer Study (BRACES): A Double-Blind Randomised Placebo-Controlled Trial. Purbadi, Sigit; Rustamadji, Primariadewi; Prijanti, Ani R.; Sekarutami, Sri M.; Sutrisna, Bambang; S Clinical report Jun 30, 2020 6646
RedHill Biopharma receives approval for COVID-19 Phase 2/3 study with opaganib. Report Jun 29, 2020 222
DRAP recommends 3 clinical studies of 2 private medical institutions. Jun 24, 2020 428
DRAP recommends 3 clinical studies of 2 private medical institutions. Jun 24, 2020 375
Corbus Pharmaceuticals reports last subject visit in Phase 2b study of lenabasum. Clinical report Jun 22, 2020 212
Dare Bioscience initiates Phase 3 study of DARE-BV1. Jun 17, 2020 316
Arecor says insulin formulation passes landmark with successful phase 1 study. Jun 16, 2020 372
BioVie to commence Phase 2 study of BIV201 this year. Clinical report Jun 11, 2020 453
RedHill Biopharma submits COVID-19 CTA for Phase 2/3 study of opaganib. Clinical report Jun 10, 2020 344
Neurocrine: Phase II crinecerfont study showed reductions in key biomarkers. Jun 8, 2020 186
FibroGen's phase 3 study of roxadustat shows non-inferiority in CKD. Clinical report Jun 8, 2020 269
Study Finds Seniors with COVID-19 Taking Hypertension Medication at Lower Risk of Hospitalisation, Clinical Trial to Follow Immediately. Jun 5, 2020 281
Orgenesis to conduct clinical study of tumor-infiltrating lymphocytes with Israeli public hospital. Clinical report Jun 2, 2020 421
Taiwan Liposome announces topline results for TLC590 Phase II trial. Clinical report May 31, 2020 230
Carrageenan-Free Diet Shows Improved Glucose Tolerance and Insulin Signaling in Prediabetes: A Randomized, Pilot Clinical Trial. Feferman, Leo; Bhattacharyya, Sumit; Oates, Erin; Haggerty, Nicole; Wang, Tianxiu; Varady, Krista; T Clinical report May 31, 2020 8749
Laser Acupuncture Alleviates Symptoms and Improves Quality of Life in Women with Overactive Bladder: A Double-Blind, Pilot Randomized Controlled Trial. Chang, Yu-Wei; Lo, Tsia-Shu; Chang, Hsin-Ning; Shiao, Yi-Hsien; Yeh, Yuan- Chieh May 31, 2020 6629
WindMIL doses first patient in Phase 2 study of MILs in combo w/ nivolumab. May 28, 2020 196
Corbus reports last subject visit in RESOLVE-1 Phase 3 study of lenabasum. Clinical report May 27, 2020 253
Study Finds Seniors with COVID-19 Taking Hypertension Medication at Lower Risk of Hospitalisation, Clinical Trial to Follow Immediately. May 20, 2020 281
Galapagos, Gilead report Phase 2B/3 results from filgotinib study. May 20, 2020 168
Kaleido Biosciences begins clinical study of KB109 in COVID-19 patients. May 14, 2020 205
Frequency Therapeutics announces data from FX-322 exploratory clinical study. Clinical report May 14, 2020 316
RedHill Biopharma gets FDA OK for COVID-19 clinical study with opaganib. May 8, 2020 294
Amgen reports 'positive' results from Otezla Phase 3 ADVANCE study. Clinical report May 6, 2020 161
Egypt's Higher Education Min. carries out 22 clinical trials to find cure for coronavirus. Walaa Ali May 5, 2020 414
Egypt carries out highest number of COVID-19 clinical trials in ME to find cure for coronavirus. Walaa Ali May 5, 2020 442
Marinus expects topline data from Phase 3 Marigold Study in Q3. May 4, 2020 170
Marinus Pharmaceuticals to transition Phase 3 Violet Study to PoC trial. May 4, 2020 246
Taste-Specific Eating Recommendation for Head and Neck Treatment Survivors: A Randomized Controlled Trial. McLaughlin, Laura Clinical report May 1, 2020 5480
General Issues in Clinical Research of Acupuncture and In Vitro Fertilization. Zheng, Cuihong; Wan, Xiaoyang; Xu, Xiaohu; Zhang, Mingmin; Huang, Guangying; Wang, Wei Apr 30, 2020 3909
Efficacy of Simple Eye Ointment, Polyethylene Cover, and Eyelid Taping in Prevention of Ocular Surface Disorders in Critically Ill Patients: A Randomized Clinical Trial. Ahmadinejad, Mehdi; Karbasi, Esmat; Jahani, Yunes; Ahmadipour, Maryam; Soltaninejad, Maryam; Karzari Clinical report Apr 30, 2020 4449
Verastem announces preliminary data from VS-6766 Phase 1 clinical study. Apr 27, 2020 321
Bio-Path announces presentation on trial design of Phase 1 study of BP1002. Apr 27, 2020 248
ONE MILLION VACCINES BY SEPTEMBER; JAB TESTS A LIGHT IN GLOOMScientists set target as trials start on volunteers. NINA MASSEY Apr 24, 2020 603
Tunisia ranks 2nd in Africa in clinical trials related to coronavirus (Eshmoun Clinical Research). Apr 24, 2020 155
British COVID-19 vaccine researches ask for volunteers for human trials. Apr 22, 2020 215
British COVID-19 vaccine researches ask for volunteers for human trials. Apr 22, 2020 219
Applied Therapeutics announces data from Phase 2 ACTION-Galactosemia trial. Apr 21, 2020 495
Incyte initiates Phase 3 RUXCOVID study in COVID-19 treatment. Apr 17, 2020 190
Humanigen wins FDA nod to commence Phase III study of lenzilumab in coronavirus patients. Apr 16, 2020 368
Millendo Therapeutics Releases Topline Results for Pivotal Phase 2b Study of Livoletide in Patients with Prader-Willi Syndrome. Clinical report Apr 7, 2020 708
Low-Dose Ketamine for Outpatient Hysteroscopy: A Prospective, Randomised, Double-Blind Study. Goswami, Devalina; Nisa, Neisevilie; Sharma, Ankur; Dadhwal, Vatsala; Baidya, Dalim Kumar; Arora, Ma Clinical report Apr 1, 2020 4884
Attitude of Asian Parkinson Patients towards Clinical Research and Tissue Donation. Khan, Shazma; Foo, Joel Y.J.; Chia, Nicole S.Y.; Agustin, Sherwin J.U.; Neo, Shermyn X.M.; Tay, Kay- Clinical report Mar 31, 2020 4478
Cassava expects topline results for Phase 2b study of PTI-125 in mid-year 2020. Clinical report Mar 26, 2020 219
Cassava expects topline results from Phase 2b study of PTI-125 mid-year 2020. Clinical report Mar 19, 2020 230
US starts clinical trial of potential COVID-19 vaccine. Mohammed El-Said Mar 18, 2020 784
Challenges of clinical research in dentistry. Pannuti, Claudio Mendes; Romito, Giuseppe Alexandre; Paiva, Saul Martins Mar 15, 2020 910
Major study proves Resolute Onyx DES meets primary endpoint in a first-ever clinical study comparing drug-eluting stents in high-bleeding risk patients with one-month DAPT. ANI Clinical report Jan 25, 2020 644
Evaluation of Concentric Periareolar Subcutaneous Mastectomy Outcomes in Transsexual Patients during 2016-2017 in Iran: A Clinical Study. Rahmati, Javad; Etemad, Omid; Mohammadi, Nafiseh Malek Clinical report Jan 1, 2020 2458
The Effects of Lutein and Zeaxanthin Supplementation on Brain Morphology in Older Adults: A Randomized, Controlled Trial. Mewborn, Catherine M.; Lindbergh, Cutter A.; Hammond, B. Randy; Renzi-Hammond, Lisa M.; Miller, L. S Dec 31, 2019 7858
Qu Biologics Completes Enrollment in First Stage of Phase 2 Clinical Trial in Moderate to Severe Crohn's Disease. Clinical report Dec 18, 2019 890
New group aids clinical research. Nov 22, 2019 159
New group aids clinical research. Nov 22, 2019 159
Saniona reports recruitment of last patient in phase 2a study for Tesomet. Clinical report Nov 12, 2019 247
Saniona reports recruitment of last patient in phase 2a study for Tesomet. Clinical report Nov 12, 2019 243
THE EFFICACY AND TOLERABILITY OF AVARICON ([R]) HEMOR MEDICAL PREPARATION IN THE TREATMENT OF HEMORRHOIDS COMPARED TO PLACEBO--A PROSPECTIVE DOUBLE BLIND RANDOMIZED CLINICAL STUDY/EFIKASNOST I PODNOSLJIVOST AVARICON[R] HEMOR MEDICINSKOG SREDSTVA U LECENJU HE-MOROIDNE BOLESTI U POREDENJU SA PLACEBOM--DVOSTRUKO SLEPA RANDOMIZIRANA PROSPEKTIVNA KLINICKA STUDIJA. Zdravkovic, Natasa; Bradic, Jovana; Zivic, Jelena; Vekic, Berislav; Bolevich, Sergey; Jakovljevic, V Clinical report Nov 1, 2019 4666
Effects of Tranexamic Acid on Bleeding and Hemoglobin Levels in Patients with Staghorn Calculi Undergoing Percutaneous Nephrolithotomy: Randomized Controlled Trial. Mohammadi, Mehrdad; Nouri-Mahdavi, Kia; Barzegar, Abbas Report Nov 1, 2019 4095
Catalyst Pharmaceuticals: Phase 3 study of CMS-001 did not meet endpoints. Oct 30, 2019 257
Catalyst Pharmaceuticals: CMS-001 Phase 3 study did not meet endpoints. Oct 30, 2019 257
LIPAC Oncology completes phase one clinical study and progresses in Phase 2A study of TBC-1002. Clinical report Oct 29, 2019 191
LIPAC Oncology completes phase one clinical study and progresses in Phase 2A study of TBC-1002. Clinical report Oct 29, 2019 187
Artelo selects Aptus Clinical as CRO for Phase 1b/2a study of ART27.13. Oct 29, 2019 185
Oracle Health Sciences and Phlexglobal Collaborate to Reduce Operational Bottlenecks in Clinical Research. Oct 24, 2019 973
Oracle Health Sciences and Phlexglobal Collaborate to Reduce Operational Bottlenecks in Clinical Research. Oct 23, 2019 715
CEL-SCI announces IDMC recommendation for Phase 3 Multikine study. Oct 15, 2019 121
Bellerophon to present new data from Cohort 1 of Phase 2/3 study of INOpulse. Clinical report Oct 14, 2019 221
India Globalization Capital announces IRB approval of IGC-AD1 for Phase 2 study. Sep 19, 2019 193
Clinical Study Of Exosome Wound Healing Begins. Sep 9, 2019 291
Canadian Small Business/Export Promotion invests CDN 100,000 in Everest Clinical Research. Sep 9, 2019 160
Canadian Small Business/Export Promotion invests CDN 100,000 in Everest Clinical Research. Sep 9, 2019 158
Artificial heart powered by China's aerospace technology to undergo clinical research. Sep 4, 2019 204
Anavex announces initiation of EXCELLENCE ANAVEX 2-73-RS-003 clinical study. Sep 4, 2019 262
The Effectiveness of Acceptance and Commitment Therapy on Insomnia Patients (A Single-arm Trial Plan)/Insomnia Hastalarinda Kabul ve Kararlilik Tedavisinin Etkililigi (Tek-kollu Calisma Plani). Zakiei, Ali; Khazaie, Habibolah Sep 1, 2019 6305
Boston Therapeutics BTI320 Phase 2 study achieves full enrollment. Aug 22, 2019 117
Bellerophon completes enrollment in cohort 2 of Phase 2/3 study of INOpulse. Clinical report Aug 1, 2019 210
Relmada Therapeutics completes dosing of last patient with REL-1017 in Phase 2 clinical study. Clinical report Jul 30, 2019 175
Relmada Therapeutics completes dosing of last patient with REL-1017 in Phase 2 clinical study. Clinical report Jul 30, 2019 171
Infant Bacterial Therapeutics reports first patient recruitment in pivotal phase III clinical study. Clinical report Jul 5, 2019 212
Infant Bacterial Therapeutics reports first patient recruitment in pivotal phase III clinical study. Clinical report Jul 5, 2019 213
Infant Bacterial Therapeutics reports first patient recruitment in pivotal phase III clinical study. Clinical report Jul 5, 2019 208
Fresenius Medical--Fresenius Medical Care expands clinical research activities--3/7/2019. Jul 5, 2019 198
Akero announces dosing of first patient in Phase 2a clinical study of AKR-001. Clinical report Jul 2, 2019 102
Telepsychiatry- Based Care for the Treatment Follow-Up of Iranian War Veterans with PostTraumatic Stress Disorder: A Randomized Controlled Trial. Haghnia, Yousef; SamadSoltani, Taha; Yousefi, Mahmood; Sadr, Habib; RezaeiHachesu, Peyman Report Jul 1, 2019 4592
New Survey Finds Fragmented Processes and System Silos Slowing Clinical Trials. Jun 24, 2019 628
Eloxx Pharmaceuticals Phase 2 study of ELX-02 receives authorization of CTA. Jun 10, 2019 180
Photobiomodulation by a 635nm Diode Laser on Peri-Implant Bone: Primary and Secondary Stability and Bone Density Analysis--A Randomized Clinical Trial. Matys, Jacek; Swider, Katarzyna; Grzech-Lesniak, Kinga; Dominiak, Marzena; Romeo, Umberto May 31, 2019 4670
Globus Medical announces results of ExcelsiusGPS clinical study published. Clinical report May 23, 2019 111
4d Pharma To Present Data From Thetanix Clinical Study In San Diego. Clinical report May 16, 2019 151
MEDI FUTURES enters into MOU with Soonchunhyang University Hospital Bucheon for Clinical Research. May 6, 2019 223
Orgenesis receives IRB approval to collect liver biopsies for planned study. Apr 30, 2019 223
Gilead Sciences' selonsertib fails to achieve primary end point in Phase three nonalcoholic steatohepatitis study. Apr 29, 2019 264
Gilead Sciences' selonsertib fails to achieve primary end point in Phase three nonalcoholic steatohepatitis study. Apr 29, 2019 260
Novus Therapeutics Releases Results of Two Single-Dose OP0201 Phase 1 Clinical Trials. Apr 23, 2019 806
Novus Therapeutics says OP0201 was 'safe and well-tolerated' in clinical trials. Clinical report Apr 22, 2019 441
Wave Life Sciences presents final results from Phase 1 suvodirsen study at MDA. Apr 16, 2019 364
Visual Performance after a Unilateral or Bilateral Implantation of Enlarged Depth-of-Focus Intraocular Lens in Patients with Cataract: A Prospective Clinical Trial. Choi, Se Hyun; Lee, Hyo kyung; Yoon, Chang Ho; Kim, Mee Kum Clinical report Mar 31, 2019 4333
Acute Efficacy of a Traditional Chinese Medicine for Treatment of Frequent Premature Ventricular Contractions in Patients with Concomitant Sinus Bradycardia: Results from a Double-Blind, Placebo-Controlled, Multicentre, Randomized Clinical Trial. Zhang, Fengxiang; Zou, Jiangang; Yu, Hao; Li, Xiaorong; Kojodjojo, Pipin; Cai, Xin; Zhang, Shu; Huan Mar 31, 2019 4589
IMV Inc. announces preliminary data from Phase 2 cohort of DECIDE study. Clinical report Mar 26, 2019 283
Sidra to host Clinical Research Methodology meet in Doha. Mar 25, 2019 253
Anavex announces first patient dosed in Phase 2 Anavex2-73 trial. Clinical report Mar 18, 2019 129
BioArctic commences phase 1 study of ABBV-0805 for Parkinson's disease. Mar 14, 2019 181
BioArctic commences phase 1 study of ABBV-0805 for Parkinson's disease. Mar 14, 2019 176
BioArctic AB (publ) starts first clinical study with ABBV-0805 in US. Mar 14, 2019 200
BioArctic commences phase 1 study of ABBV-0805 for Parkinson's disease. Mar 14, 2019 180
BioArctic AB (publ) starts first clinical study with ABBV-0805 in US. Mar 14, 2019 204
Marinus Pharmaceuticals initiates Phase 3 Violet Study. Mar 6, 2019 218
Immune Reconstitution Data From Phase 1/2 Clinical Study Of Transplant Therapy Presented. Clinical report Mar 4, 2019 561
Immune Reconstitution Data From Phase 1/2 Clinical Study Of Transplant Therapy Presented. Clinical report Mar 4, 2019 561
Gamida Cell Presents Immune Reconstitution Data from Completed Phase 1/2 Clinical Study of NiCord. Clinical report Feb 25, 2019 741
Clinical research must be part and parcel of public health system (minister). Feb 7, 2019 192
Momenta reports first subject dosed in Phase 1/2 trial of M254. Clinical report Jan 29, 2019 139
Adapting data management education to support clinical research projects in an academic medical center. Read, Kevin B. Case study Jan 1, 2019 4766
A Randomized, Controlled Trial of Notched Music Therapy for Tinnitus Patients. Atipas, Suvajana; Therdphaothai, Jaturong; Suvansit, Kanokrat; Prakairungthong, Sarun; Thongyai, Kan Jan 1, 2019 4502
The effectiveness of manual lymphatic drainage and low level laser in the treatment of a client with lipedema: an N-of-1 trial. Balinski, Angela; Grace, Sandra; Avila, Cathy; Bradbury, Jo Dec 22, 2018 1462
U of M seeks designs for clinical research building. Dec 7, 2018 662
Spectrum announces RECOVER Phase 3 study of ROLONTIS meets primary endpoint. Dec 6, 2018 276
aTyr Pharma reports initiation of Phase 1b/2a study of ATYR1923. Dec 4, 2018 169
Gamida Cell publishes data from Phase 1/2 clinical study of NiCord. Clinical report Dec 4, 2018 135
Quality Measurement and Improvement Study of Surgical Coronary Revascularization: Medication Adherence (MISSION-2). Liu, Chong-Yang; Du, Jun-Zhe; Rao, Chen-Fei; Zhang, Heng; Liu, Han-Ning; Zhao, Yan; Yang, Li-Meng; L Report Dec 1, 2018 6936
Novus Therapeutics Doses First Subjects in Phase 1 Study of OP0201. Nov 29, 2018 306
Nektar presents new results from PIVOT-02 Phase 1/2 Study. Nov 9, 2018 264
InflaRx completes enrollment in IFX-1 Phase IIb clinical trial. Clinical report Nov 8, 2018 157
Sublingual Immunotherapy Tablets Relieve Symptoms in Adults with Allergic Rhinitis: A Meta-analysis of Randomized Clinical Trials. Li, Yi; Yu, Shi-Yuan; Tang, Rui; Zhao, Zuo-Tao; Sun, Jin-Lyu Report Nov 5, 2018 4235
Comment to 'Recurrent Glioblastoma Treated with Recombinant Poliovirus'. Wang, Peng; Chen, Guang-Zhong Report Nov 5, 2018 708
Anavex announces first patient enrolled in Phase 2 ANAVEX2-73 study for PDD. Clinical report Oct 30, 2018 112
Symphony Clinical Research earns recertification. Oct 10, 2018 178
Viking Therapeutics: VK2809 Phase 2 study results selected for presentation. Report Oct 4, 2018 172
Viking Therapeutics says Phase 2 study of VK5211 achieves primary endpoint. Oct 1, 2018 550
A NON-RANDOMISED CONTROLLED TRIAL STUDY BETWEEN NIFEDIPINE AND ISOXSUPRINE AS TOCOLYTICS FOR PRE-TERM LABOUR. Kundu, Mrinal Kanti; Saha, Manas Kumar; Das, Kamalika Report Oct 1, 2018 2770
Hansa Medical's two phase 2 studies report positive final top line results for Imlifidase for kidney transplantation. Sep 28, 2018 228
Hansa Medical's two phase 2 studies report positive final top line results for Imlifidase for kidney transplantation. Sep 28, 2018 229
Hansa Medical's two phase 2 studies report positive final top line results for Imlifidase for kidney transplantation. Sep 28, 2018 224
Ionis Pharmaceuticals announces results from Phase 2 study of AKCEA-APO-L. Clinical report Sep 24, 2018 179
Abbott announces positive clinical study results from MitraClip trial. Clinical report Sep 23, 2018 317
GTx annnounces placebo-controlled ASTRID trial did not meet primary endpoint. Sep 21, 2018 196
JAMA publishes Phase III study using 22nd Century's SPECTRUM cigarettes. Clinical report Sep 5, 2018 317
An audit of clinical trials registered at clinical trial registry of India in 2017. Panchasara, Ashwin K.; Chawda, Hiren M. Report Sep 1, 2018 1495
Electromed 'thrilled' by results of independent clinical study. Clinical report Aug 14, 2018 149
Ovid Therapeutics says Phase 2 STARS Trial of OV101 achieved primary endpoint. Clinical report Aug 6, 2018 583
The First Successful Uterus Transplantation in the Mena Region Under Clinical Research. Jul 31, 2018 365
Cerprobe to commence Phase 3 study of lenabasum. Clinical report Jul 25, 2018 194
Tools, Methods of RCTs Can Be Adapted to Real-World Settings; 3 options described for applying approaches used in randomized controlled trials to real-world data. Jul 25, 2018 252
Alligator Bioscience files application for clinical phase I study of ATOR-1015 in cancer patients. Jul 20, 2018 216
Alligator Bioscience files application for clinical phase I study of ATOR-1015 in cancer patients. Jul 20, 2018 217
Alligator Bioscience files application for clinical phase I study of ATOR-1015 in cancer patients. Jul 20, 2018 212
Luspatercept achieved primary and key secondary endpoints in Phase III study. Clinical report Jul 9, 2018 314
Anavex receives approval to initiate Phase 2b/3 clinical trial of AVANEX 2-73. Jul 3, 2018 143
Positive Axilla in Breast Cancer; Clinical Practice in 2018. Isi, Arda; Grassi, Arial; Soran, Atilla Report Jul 1, 2018 1554
Luspatercept achieved primary and secondary endpoints in Phase 3 MEDALIST study. Clinical report Jun 28, 2018 158
Ritter Pharmaceuticals initiates first pivotal Phase 3 trial for RP-G28. Clinical report Jun 27, 2018 219
Cytokinetics announces data from Phase 2 clinical study of Reldesemtiv in SMA. Clinical report Jun 17, 2018 234
Pluristem reports 'positive' results from Phase II clinical study of PLX-PAD. Clinical report Jun 12, 2018 216
Deciphera reports updated interim phase 1 clinical study results with DCC-2618. Jun 3, 2018 305
NeuroVive Pharmaceutical and Yungjin Pharm jointly report positive KL1333 phase I clinical study results. May 22, 2018 324
NeuroVive Pharmaceutical and Yungjin Pharm jointly report positive KL1333 phase I clinical study results. May 22, 2018 320
Microbot Medical completes pre-clinical study for Self-Cleaning Shunt. Clinical report May 21, 2018 155
Nurses' Knowledge, Attitudes and Opinions Towards Clinical Research: A Cross-Sectional Study in a University Hospital. Aksoy, Hacer Bulut; Arici, M. Aylin; Ucku, Reyhan; Gelal, Ayse May 1, 2018 6308
A CLINICAL STUDY ON LAPAROTOMY FINDINGS IN BLUNT INJURY ABDOMEN. Naik, Mudavatu Bhagavan; Navamani, Gali Satya; Durganeelima, E.V. Report Apr 30, 2018 2227
Eli Lilly says Phase 3 RANGE study didn't reach statistical significance for OS. Apr 20, 2018 192
Anavex to initiate ANAVEX2-73 Phase 2 study in PDD. Apr 17, 2018 120
Avita Medical announces clinical study results of RECELL. Clinical report Apr 12, 2018 175
Comparison of conservative exercise therapy with and without Maitland Thoracic Manipulative therapy in patients with subacromial pain: Clinical trial. Mar 31, 2018 3206
Onconova presents 'promising' clinical safety data from Phase 2 expansion study. Mar 26, 2018 388
Parexel to Collaborate with CHA Medical Group to Improve Early Phase Clinical Research in Korea. Mar 15, 2018 200
Enrollment Completed in Stealth BioTherapeutics Study of Elamipretide for Treatment of Barth Syndrome. Mar 9, 2018 203

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |